UBS Group’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4M | Buy |
404,702
+140,312
| +53% | +$9.16M | ﹤0.01% | 1640 |
|
|
2025
Q1 | $17.7M | Sell |
264,390
-330,420
| -56% | -$22.1M | ﹤0.01% | 1889 |
|
|
2024
Q4 | $32.9M | Buy |
594,810
+308,322
| +108% | +$17M | 0.01% | 1391 |
|
|
2024
Q3 | $17.1M | Buy |
286,488
+254,514
| +796% | +$15.2M | ﹤0.01% | 1377 |
|
|
2024
Q2 | $2.04M | Buy |
31,974
+14,512
| +83% | +$924K | ﹤0.01% | 2841 |
|
|
2024
Q1 | $1.21M | Sell |
17,462
-1,569
| -8% | -$108K | ﹤0.01% | 3421 |
|
|
2023
Q4 | $1.05M | Buy |
19,031
+12,853
| +208% | +$709K | ﹤0.01% | 3400 |
|
|
2023
Q3 | $359K | Sell |
6,178
-25,895
| -81% | -$1.5M | ﹤0.01% | 3840 |
|
|
2023
Q2 | $1.73M | Buy |
32,073
+20,376
| +174% | +$1.1M | ﹤0.01% | 2817 |
|
|
2023
Q1 | $465K | Buy |
11,697
+4,880
| +72% | +$194K | ﹤0.01% | 3759 |
|
|
2022
Q4 | $274K | Buy |
6,817
+6,773
| +15,393% | +$272K | ﹤0.01% | 4151 |
|
|
2022
Q3 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 8808 |
|
|
2022
Q2 | – | Sell |
-481
| Closed | -$14K | – | 9212 |
|
|
2022
Q1 | $14K | Sell |
481
-5,420
| -92% | -$158K | ﹤0.01% | 6873 |
|
|
2021
Q4 | $273K | Buy |
5,901
+4,274
| +263% | +$198K | ﹤0.01% | 4407 |
|
|
2021
Q3 | $53K | Sell |
1,627
-733
| -31% | -$23.9K | ﹤0.01% | 5189 |
|
|
2021
Q2 | $83K | Sell |
2,360
-1,603
| -40% | -$56.4K | ﹤0.01% | 4977 |
|
|
2021
Q1 | $144K | Sell |
3,963
-1,030
| -21% | -$37.4K | ﹤0.01% | 4709 |
|
|
2020
Q4 | $145K | Sell |
4,993
-2,988
| -37% | -$86.8K | ﹤0.01% | 4476 |
|
|
2020
Q3 | $226K | Sell |
7,981
-10,009
| -56% | -$283K | ﹤0.01% | 3914 |
|
|
2020
Q2 | $581K | Buy |
17,990
+10,373
| +136% | +$335K | ﹤0.01% | 3270 |
|
|
2020
Q1 | $311K | Sell |
7,617
-7,578
| -50% | -$309K | ﹤0.01% | 3568 |
|
|
2019
Q4 | $937K | Buy |
15,195
+5,521
| +57% | +$340K | ﹤0.01% | 3398 |
|
|
2019
Q3 | $706K | Buy |
9,674
+5,384
| +126% | +$393K | ﹤0.01% | 3457 |
|
|
2019
Q2 | $353K | Buy |
4,290
+4,170
| +3,475% | +$343K | ﹤0.01% | 3757 |
|
|
2019
Q1 | $8K | Sell |
120
-98
| -45% | -$6.53K | ﹤0.01% | 6085 |
|
|
2018
Q4 | $10K | Sell |
218
-1,536
| -88% | -$70.5K | ﹤0.01% | 6297 |
|
|
2018
Q3 | $99K | Buy |
1,754
+1,085
| +162% | +$61.2K | ﹤0.01% | 4739 |
|
|
2018
Q2 | $45K | Sell |
669
-835
| -56% | -$56.2K | ﹤0.01% | 5154 |
|
|
2018
Q1 | $88K | Buy |
1,504
+1,208
| +408% | +$70.7K | ﹤0.01% | 4466 |
|
|
2017
Q4 | $19K | Sell |
296
-2,496
| -89% | -$160K | ﹤0.01% | 5618 |
|
|
2017
Q3 | $147K | Buy |
2,792
+558
| +25% | +$29.4K | ﹤0.01% | 4202 |
|
|
2017
Q2 | $105K | Sell |
2,234
-2,378
| -52% | -$112K | ﹤0.01% | 4256 |
|
|
2017
Q1 | $228K | Sell |
4,612
-2,287
| -33% | -$113K | ﹤0.01% | 3753 |
|
|
2016
Q4 | $418K | Sell |
6,899
-12,388
| -64% | -$751K | ﹤0.01% | 3441 |
|
|
2016
Q3 | $1.28M | Buy |
19,287
+4,748
| +33% | +$315K | ﹤0.01% | 2584 |
|
|
2016
Q2 | $812K | Buy |
14,539
+12,613
| +655% | +$704K | ﹤0.01% | 2851 |
|
|
2016
Q1 | $65K | Sell |
1,926
-29
| -1% | -$979 | ﹤0.01% | 4512 |
|
|
2015
Q4 | $88K | Buy |
1,955
+1,896
| +3,214% | +$85.3K | ﹤0.01% | 4317 |
|
|
2015
Q3 | $2K | Sell |
59
-8,590
| -99% | -$291K | ﹤0.01% | 6561 |
|
|
2015
Q2 | $537K | Buy |
8,649
+5,930
| +218% | +$368K | ﹤0.01% | 3215 |
|
|
2015
Q1 | $170K | Buy |
2,719
+1,969
| +263% | +$123K | ﹤0.01% | 3883 |
|
|
2014
Q4 | $42K | Buy |
+750
| New | +$42K | ﹤0.01% | 4866 |
|